Miwako Inagaki Selected Research

Miwako Inagaki Research Topics

6	Hyperlipidemias (Hyperlipidemia) 09/2012 - 09/2010
5	Atherosclerosis 10/2013 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 10/2008
2	Inflammation (Inflammations) 10/2013 - 01/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2012 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 09/2010
2	Platelet Glycoprotein IV Deficiency 01/2012 - 06/2010
2	Coronary Disease (Coronary Heart Disease) 09/2011 - 12/2009
2	Hypertriglyceridemia 09/2010 - 06/2010
1	Insulin Resistance 12/2012
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2012
1	Obesity 09/2010
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 12/2009
1	Tangier Disease 06/2009

5	Apolipoprotein B-48IBA 09/2012 - 01/2011
4	Lipoproteins (Lipoprotein)IBA 12/2012 - 01/2011
3	CholesterolIBA 12/2012 - 10/2008
3	oxidized low density lipoproteinIBA 12/2012 - 12/2009
3	HDL LipoproteinsIBA 01/2012 - 10/2008
3	Triglycerides (Triacylglycerol)IBA 01/2012 - 01/2011
2	AdiponectinIBA 12/2012 - 10/2008
2	ChylomicronsIBA 09/2012 - 09/2011
2	HDL CholesterolIBA 06/2010 - 10/2008
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	ProgranulinsIBA 10/2013
1	Apolipoproteins E (ApoE)IBA 10/2013
1	Glucose (Dextrose)FDA LinkGeneric 09/2012
1	ApolipoproteinsIBA 09/2012
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Chylomicron RemnantsIBA 09/2012
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2012
1	AntioxidantsIBA 01/2012
1	Probucol (Lorelco)FDA Link 01/2012
1	CD36 AntigensIBA 01/2012
1	Ezetimibe (Zetia)FDA Link 09/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010
1	Fenofibrate (CiL)FDA LinkGeneric 06/2010
1	polyacrylamideIBA 12/2009
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2009
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2009
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2008
1	PPAR gammaIBA 10/2008